
University of Medicine and Pharmacy of Craiova
University of Medicine and Pharmacy of Craiova
4 Projects, page 1 of 1
assignment_turned_in ProjectPartners:Amasya University, University of Craiova, University of Medicine and Pharmacy of Craiova, Regional academic center of BAS Burgas, WSBiNoZAmasya University,University of Craiova,University of Medicine and Pharmacy of Craiova,Regional academic center of BAS Burgas,WSBiNoZFunder: European Commission Project Code: 2022-1-RO01-KA220-HED-000085385Funder Contribution: 250,000 EUR<< Objectives >>Our project aim to offer an e-course addressing to COVID 19 simptoms, complications, treatment and recovery delivered by a tele-medicine platform. This will support medical university students in last years of study in acquisition of new skills as requested by the labor market in present pandemic context. In this way we bring our contribution to help the medical sector recover from the crisis in terms of innovative digital solutions in line with the EU’s strategic priorities<< Implementation >>E-MED intends to develop and implement an interactive model of learning and training in medical Higher Education, encompassing the benefits of e-learning with innovative work-based approaches. This will enhance theoretical and practical knowledge regarding COVID 19 disease for 200 medical students in participant HEIs. Activities: development of new curricula and COVID 19 on line course included into the e-MED e-learning platform; development and implementation of tele-medicine approaches.<< Results >>Tangible and intangible results can be summarized:- new curricula and COVID 19 on line course included into e-MED e-learning platform- virtual environment for on line consultation/telemedicine- development of digital skills and competences for medical students and teachers to use on-line medical approaches-strengthening partner organizations capacity to respond to actual challenges and to develop digital dimension of LL within organizations
more_vert Open Access Mandate for Publications assignment_turned_in Project2013 - 2017Partners:LSHTM, University of Otago, UMCG, EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH, University of Medicine and Pharmacy of Craiova +7 partnersLSHTM,University of Otago,UMCG,EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH,University of Medicine and Pharmacy of Craiova,STICHTING RADBOUD UNIVERSITEIT,Universidad Peruana Cayetano Heredia,SU,LUMC,SGUL,MPG,UNPADFunder: European Commission Project Code: 305279more_vert assignment_turned_in Project2012 - 2017Partners:KLINIKUM DER UNIVERSITAET ZU KOELN, TAU, ISS, MONIPOL SP ZOO, INRAE +44 partnersKLINIKUM DER UNIVERSITAET ZU KOELN,TAU,ISS,MONIPOL SP ZOO,INRAE,LANDSPITALI UNIVERSITY HOSPITAL,BIOCRUCES,ECRIN,St Olav,FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA,EORTC,NOVA,EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION,KI,MU,VSOP,MMI,SCTO,AMU,CAIBER,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,MUI,SERGAS,IRCCS,REGIONH,Medical University of Vienna,AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM,University of Medicine and Pharmacy of Craiova,ESPEN,HHU,HUNGAROTRIAL,UMC,Luxembourg Institute of Health,DEÜ,UZH,FinnMedi,EGESZSEGUGY MINISZTERIUMI,FCM-UNL,SLD SMS,UP,Mario Negri Institute for Pharmacological Research,Amsterdam UMC,Medical University of Warsaw,UniTransferKlinik,Qualissima (France),University of Leeds,CIRM,CTCM,FMNSFunder: European Commission Project Code: 284395more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2023 - 2027Partners:Instituto de Saúde Pública da Universidade do Porto, University of Medicine and Pharmacy of Craiova, ISGLOBAL, University of Novi Sad, EUPHA +15 partnersInstituto de Saúde Pública da Universidade do Porto,University of Medicine and Pharmacy of Craiova,ISGLOBAL,University of Novi Sad,EUPHA,TUM,UMT,TAU,MFUNS UNIVERSITY OF NOVI SAD FACULTY OF MEDICINE,Sapienza University of Rome,ULB,LOGOS,SOCIETY PSYCHIATRISTS NARCOLOGISTS,University of Cagliari,Universität Augsburg,University of Applied Sciences Emden Leer,WONCA EUROPE,GAMIAN EUROPE,MUG,ASPHERFunder: European Commission Project Code: 101095392Overall Budget: 3,014,770 EURFunder Contribution: 3,014,770 EUREARLY project aims to reduce the burden of non-communicable diseases such as mental health conditions (MHC), especially depression, anxiety, stress disorders, substance use disorders and identify and reduce risky modifiable exposures for these conditions in youth. EARLY will pursue this goal through developing a comprehensive exposure matrix which can be adapted to emerging new risks, to understand youth, parents`, and stakeholders perceptions, we will conduct qualitative, interviews, by providing representative, multinational data on youth MHC and through developing, implementing and evaluating a multicomponent intervention. This will serve as an innovative model for promoting mental health and preventing MHC. EARLY is a mixed methods study which combines qualitative and quantitative methods. To provide a overview on youth mental health measures we will review measures, to provide data on exposure factors and whether exposure estimates vary by country, age, and gender, we will review studies and identify and merge available data on youth mental health; to provide insights on perceptions we will conduct focus groups with end-users. To provide representative data on youth MHC we will conduct a cross-sectional survey which are the baseline data for the multicomponent pilot intervention in five selected countries. To provide data on effectiveness and sustainability of interventions to reduce MHC we will conduct a multicomponent intervention. The results will be a a) model of youth mental health, b) a matrix of exposures, c) insights and understandings on end-users perceptions of youth mental health, d) knowledge on services for use in the European region and identification of needs; e) representative data on youth mental health which can be easily accessed by researchers and policymakers; f) data on effectiveness and sustainability of interventions to reduce both exposures and MHC in youth and finally g) non-communicable diseases risk reduction in adolescence and youth.
more_vert